OrbiMed is a dedicated healthcare investment firm with investments ranging from biopharmaceuticals to medical devices, diagnostics, and healthcare services.

The firm invests across the global healthcare industry, from seed-stage venture capital to large, publicly traded companies.

Investments are made through public equity, private equity, or royalty opportunities.OrbiMed was founded in 1989 and is headquartered in New York, with offices in San Francisco, Mumbai, Hong Kong, and Shanghai.